Neuroimmunology News

Apr 28, 2019
FDA approves first treatment for pediatric patients with lupus
Drug fulfils unmet need for therapies, specifically in pediatric patients with systemic lupus erythematosus.
Apr 16, 2019
Non-invasive vagus nerve stimulation shows promise for treatment of rheumatoid arthritis
Research suggests that noninvasive stimulation could suppress inflammation in patients with rheumatoid arthritis.
Apr 08, 2019
Study of patients with multiple sclerosis shows 18 percent misdiagnosed
Investigators hope that the study results will help improve diagnostic procedures and prevent future multiple sclerosis misdiagnoses.
Apr 03, 2019
Do minerals play a role in development of multiple sclerosis?
New study shows no link between dietary intake of several minerals and whether people later develop multiple sclerosis.
Mar 27, 2019
FDA approves new oral drug to treat multiple sclerosis
New drug approved to treat adults with relapsing forms of multiple sclerosis.
Mar 08, 2019
Pediatric onset multiple sclerosis study examines baffling, often-overlooked disease
Because children often present with different symptoms than adults, educational campaigns are needed to help health care providers recognize the symptoms of pediatric-onset multiple sclerosis.
Mar 05, 2019
Sugar-sweetened beverages linked to more severe symptoms for people with multiple sclerosis
Drinking around 290 calories per day of soda or other sugar-sweetened beverages may be tied to more severe symptoms and a higher level of disability.
Feb 14, 2019
Chronic inflammation in middle age may lead to thinking and memory problems later
Feb 13, 2019
Almost 1 in 5 people wrongly diagnosed with multiple sclerosis at two specialized centers in US
Almost 1 in 5 patients diagnosed with multiple sclerosis and referred to one of 2 multiple sclerosis-specialized centers in the US were found to not have the disease.
Oct 16, 2018
Environmental factors may trigger onset of multiple sclerosis
Structural changes to protective neural membranes may be involved in onset of neurodegenerative disease, Tel Aviv University researchers say.
◀ Previous   Next ▶